Significant association between serum interleukin-6 and helicobacter pylori antibody levels among h. pylori -positive japanese adults

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Nakagawa, Hiroko ^a   Tamura, Takashi ^a   Mitsuda, Yoko ^a   Goto, Yasuyuki ^a   Kamiya, Yoshikazu ^b   Kondo, Takaaki ^a   Wakai, Kenji ^a   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization Higashi Nagoya National Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; UREA C 13; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ATROPHIC GASTRITIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CENTER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URBAN AREA; UREA BREATH TEST; YOUNG ADULT; BLOOD; CORONARY ARTERY DISEASE; IMMUNOLOGY; STATISTICAL MODEL;

ADULT; AGED; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 84896111480     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/142358     Document Type: Article

References (40)

1. Hirano T., Akira S., Taga T., Kishimoto T., Biological and clinical aspects of interleukin 6. Immunology Today 1990 11 12 443 449 2-s2.0-0025226107
2. Horii Y., Muraguchi A., Iwano M., Matsuda T., Hirayama T., Yamada H., Fujii Y., Dohi K., Ishikawa H., Ohmoto Y., Yoshizaki K., Hirano T., Kishimoto T., Involvement of IL-6 in mesangial proliferative glomerulonephritis. Journal of Immunology 1989 143 12 3949 3955 2-s2.0-0024805715 (Pubitemid 20012578)
3. Hansson G. K., Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005 352 16 1685 1695 2-s2.0-17644412023 10.1056/NEJMra043430 (Pubitemid 40530235)
4. Mehta J. L., Saldeen T. G. P., Rand K., Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. Journal of the American College of Cardiology 1998 31 6 1217 1225 2-s2.0-0032080553 10.1016/S0735-1097(98)00093-X (Pubitemid 28219109)
5. Ikonomidis I., Stamatelopoulos K., Lekakis J., Vamvakou G. D., Kremastinos D. T., Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008 199 1 3 11 2-s2.0-46149124076 10.1016/j.atherosclerosis. 2008.02.019
6. Zakynthinos E., Pappa N., Inflammatory biomarkers in coronary artery disease. Journal of Cardiology 2009 53 3 317 333 2-s2.0-65849453194 10.1016/j.jjcc.2008.12.007
7. Berk B. C., Weintraub W. S., Alexander R. W., Elevation of C-reactive protein in "active" coronary artery disease. American Journal of Cardiology 1990 65 3 168 172 2-s2.0-0025177196 10.1016/0002-9149(90)90079-G (Pubitemid 20031251)
8. Thompson S. G., Kienast J., Pyke S. D. M., Haverkate F., Van de Loo J. C., Luscher E. F., Boissel J. P., Brakman P., Julian D. G., Prentice C. R. M., Verstraete M., Haverkate F., Bricaud H., Duckert F., Hugenholtz P. G., Lubsen J., Muller U. S., Breithardt G., Brochier M., Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. The New England Journal of Medicine 1995 332 10 635 641 2-s2.0-0028909230 10.1056/NEJM199503093321003
9. Buckley D. I., Fu R., Freeman M., Rogers K., Helfand M., C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. preventive services task force. Annals of Internal Medicine 2009 151 7 483 495 2-s2.0-70349742564
10. Mortensen R. F., C-reactive protein, inflammation, and innate immunity. Immunologic Research 2001 24 2 163 176 2-s2.0-0034822711 10.1385/IR:24:2:163 (Pubitemid 32897076)
11. Koenig W., Khuseyinova N., Baumert J., Thorand B., Loewel H., Chambless L., Meisinger C., Schneider A., Martin S., Kolb H., Herder C., Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2745 2751 2-s2.0-33751191631 10.1161/01.ATV.0000248096.62495.73
12. Lobbes M. B., Lutgens E., Heeneman S., Cleutjens K. B., Kooi M. E., van Engelshoven J. M., Daemen M. J., Nelemans P. J., Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 2006 187 1 18 25 2-s2.0-33744548144 10.1016/j.atherosclerosis.2005.11.005 (Pubitemid 43817018)
13. Danesh J., Kaptoge S., Mann A. G., Sarwar N., Wood A., Angleman S. B., Wensley F., Higgins J. P. T., Lennon L., Eiriksdottir G., Rumley A., Whincup P. H., Lowe G. D. O., Gudnason V., Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Medicine 2008 5 4, article e78 2-s2.0-43249118045 10.1371/journal.pmed.0050078 (Pubitemid 351649259)
14. Su D., Li Z., Li X., Chen Y., Zhang Y., Ding D., Deng X., Xia M., Qiu J., Ling W., Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease. Mediators of Inflammation 2013 2013 7 726178 10.1155/2013/726178
15. Lindmark E., Diderholm E., Wallentin L., Siegbahn A., Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. The Journal of the American Medical Association 2001 286 17 2107 2113 2-s2.0-0035824178 (Pubitemid 34041595)
16. Mendall M. A., Goggin P. M., Molineaux N., Levy J., Toosy T., Strachan D., Camm A. J., Northfield T. C., Relation of Helicobacter pylori infection and coronary heart disease. British Heart Journal 1994 71 5 437 439 2-s2.0-0028431004 (Pubitemid 2068912)
17. Kinjo K., Sato H., Sato H., Shiotani I., Kurotobi T., Ohnishi Y., Hishida E., Nakatani D., Mizuno H., Sasaki T., Kohama A., Abe Y., Morita H., Kubo M., Takeda H., Hori M., Masatsugu H., Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circulation Journal 2002 66 9 805 810 2-s2.0-0036731607 (Pubitemid 34988214)
18. Osawa H., Kawakami M., Fujii M., Kubo N., Iwanaka H., Yamamoto W., Saitoh M., Yaginuma T., Sugano K., Helicobacter pylori infection and coronary heart disease in Japanese patients. Cardiology 2001 95 1 14 19 2-s2.0-0034980486 10.1159/000047337 (Pubitemid 32506955)
19. Pasceri V., Cammarota G., Patti G., Cuoco L., Gasbarrini A., Grillo R. L., Fedeli G., Gasbarrini G., Maseri A., Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998 97 17 1675 1679 2-s2.0-0032485913 (Pubitemid 28211415)
20. Danesh J., Youngman L., Clark S., Parish S., Peto R., Collins R., Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. British Medical Journal 1999 319 7218 1157 1162 2-s2.0-0033619454 (Pubitemid 29502017)
21. Mayr M., Kiechl S., Mendall M. A., Willeit J., Wick G., Xu Q., Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003 34 3 610 615 2-s2.0-0037335827 10.1161/01.STR.0000058481.82639.EF (Pubitemid 36307380)
22. Franceschi F., Niccoli G., Ferrante G., Gasbarrini A., Baldi A., Candelli M., Feroce F., Saulnier N., Conte M., Roccarina D., Lanza G. A., Gasbarrini G., Gentiloni S. N., Crea F., CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009 202 2 535 542 2-s2.0-58549111583 10.1016/j.atherosclerosis.2008.04.051
23. Koenig W., Rothenbacher D., Hoffmeister A., Miller M., Bode G., Adler G., Hombach V., März W., Pepys M. B., Brenner H., Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999 100 23 2326 2331 2-s2.0-0033534057
24. Stone A. F., Risley P., Markus H. S., Butland B. K., Strachan D. P., Elwood P. C., Mendall M. A., Ischaemic heart disease and Cag a strains of Helicobacter pylori in the Caerphilly heart disease study. Heart 2001 86 5 506 509 2-s2.0-0034778875 (Pubitemid 32999859)
25. Pellicano R., Parravicini P. P., Bigi R., Gandolfo N., Aruta E., Gai V., Figura N., Angelino P., Rizzetto M., Ponzetto A., Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? New Microbiologica 2002 25 3 315 321 2-s2.0-0036653286 (Pubitemid 135747295)
26. Whincup P., Danesh J., Walker M., Lennon L., Thomson A., Appleby P., Hawkey C., Atherton J., Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000 101 14 1647 1652 2-s2.0-0034636060 (Pubitemid 30196623)
27. Murray L. J., Bamford K. B., Kee F., McMaster D., Cambien F., Dallongeville J., Evans A., Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction. Atherosclerosis 2000 149 2 379 385 2-s2.0-0034017385 10.1016/S0021-9150(99)00325-1 (Pubitemid 30145548)
28. Yudkin J. S., Stehouwer C. D. A., Emeis J. J., Coppack S. W., C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 4 972 978 2-s2.0-0032943709 (Pubitemid 29177345)
29. Miki K., Ichinose M., Shimizu A., Huang S. C., Oka H., Furihata C., Matsushima T., Takahashi K., Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterologia Japonica 1987 22 2 133 141 2-s2.0-0023195645 (Pubitemid 17065789)
30. Stemmermann G. N., Samloff I. M., Nomura A. M. Y., Heilbrun L. K., Serum pepsinogens I and II and stomach cancer. Clinica Chimica Acta 1987 163 2 191 198 2-s2.0-0023156415 (Pubitemid 17046077)
31. Kodoi A., Yoshihara M., Sumii K., Haruma K., Kajiyama G., Serum pepsinogen in screening for gastric cancer. Journal of Gastroenterology 1995 30 4 452 460 2-s2.0-0029095227 10.1007/BF02347560
32. Miki K., Urita Y., Using serum pepsinogens wisely in a clinical practice. Journal of Digestive Diseases 2007 8 1 8 14 2-s2.0-43649098078 10.1111/j.1443-9573.2007.00278.x (Pubitemid 46189204)
33. Mizuno S., Kobayashi M., Tomita S., Miki I., Masuda A., Onoyama M., Habu Y., Inokuchi H., Watanabe Y., Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer 2009 12 3 158 163 2-s2.0-73449125856 10.1007/s10120-009-0522-y
34. Amedei A., Munari F., Bella C. D., Niccolai E., Benagiano M., Bencini L., Cianchi F., Farsi M., Emmi G., Zanotti G., de Bernard M., Kundu M., D'Elios M. M., Helicobacter pylori secreted peptidyl prolyl cis, trans -isomerase drives Th17 inflammation in gastric adenocarcinoma. Internal and Emergency Medicine 2012 10.1007/s11739-012-0867-9
35. Benagiano M., Munari F., Ciervo A., Amedei A., Paccani S. R., Mancini F., Ferrari M., Della Bella C., Ulivi C., D'Elios S., Baldari C. T., Prisco D., De Bernard M., D'Elios M. M., Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 2012 109 4 1222 1227 2-s2.0-84856369177 10.1073/pnas.1111833109
36. Manolakis A., Kapsoritakis A. N., Potamianos S. P., A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter 2007 12 4 287 297 2-s2.0-34547573552 10.1111/j.1523-5378.2007.00511.x (Pubitemid 47196336)
37. Alkout A. M., Ramsay E. J., Mackenzie D. A. C., Weir D. M., Bentley A. J., Elton R. A., Sutherland S., Busuttil A., Blackwell C. C., Quantitative assessment of IgG antibodies to Helicobacter pylori and outcome of ischaemic heart disease. FEMS Immunology and Medical Microbiology 2000 29 4 271 274 2-s2.0-0033664574 10.1016/S0928-8244(00)00216-9
38. Novák J., Szekanecz Z., Sebesi J., Takáts A., Demeter P., Bene L., Sipka S., Csiki Z., Elevated levels of anti- Helicobacter pylori antibodies in Henoch-Schönlein purpura. Autoimmunity 2003 36 5 307 311 2-s2.0-0042063668 10.1080/08916930232000114535 (Pubitemid 36992451)
39. Yamamoto I., Fukuda Y., Mizuta T., Fukada M., Nishigami T., Shimoyama T., Serum anti- Helicobacter pylori antibodies and gastritis. Journal of Clinical Gastroenterology 1995 21 1, supplment 1 S164 S168 2-s2.0-0029619775 (Pubitemid 26001739)
40. Kreuning J., Lindeman J., Biemond I., Lamer C. B., Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity gastritis in asymptomatic subjects. Journal of Clinical Pathology 1994 47 3 227 231 2-s2.0-0028325853 (Pubitemid 24120684)